Clinical trial • Phase III • Psychiatry
Clinical trial in Healthy volunteers
Phase III trial for Healthy volunteers. None/Not specified-controlled. 54 participants.
Overview
- Trial Therapeutic Area
- Psychiatry
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 17-10-2023
- First CTIS Authorization Date
- 06-02-2024
Trial design
None/Not specified-controlled Phase III trial across 1 site in Netherlands.
- Comparator
- None/Not specified
- Target Sample Size
- 54
Recruitment
- Planned Sample Size
- 54
- Recruitment Window Months
- 19
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 54
Netherlands
- Earliest CTIS Part Ii Submission Date
- 21-12-2023
- Latest Decision Or Authorization Date
- 04-10-2024
- Processing Time Days
- 288
- Number Of Sites
- 1
- Number Of Participants
- 54
Sites
- Site Name
- De Zwaaikom 4
- Department Name
- Clinical Research Unit
- Contact Person Name
- Matthijs Bossong
- Contact Person Email
- m.bossong@bedrocan.com
- Number Of Participants
- 54
Sponsor
Primary sponsor
- Full Name
- Bedrocan International B.V.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Netherlands
Related trials
Other published trials that may interest you.